Growth Metrics

Inogen (INGN) Cost of Revenue (2016 - 2022)

Historic Cost of Revenue for Inogen (INGN) over the last 10 years, with Q3 2022 value amounting to $62.6 million.

  • Inogen's Cost of Revenue rose 3781.1% to $62.6 million in Q3 2022 from the same period last year, while for Sep 2022 it was $202.9 million, marking a year-over-year increase of 1408.41%. This contributed to the annual value of $181.5 million for FY2021, which is 658.4% up from last year.
  • According to the latest figures from Q3 2022, Inogen's Cost of Revenue is $62.6 million, which was up 3781.1% from $57.1 million recorded in Q2 2022.
  • Inogen's Cost of Revenue's 5-year high stood at $62.6 million during Q3 2022, with a 5-year trough of $37.8 million in Q4 2021.
  • For the 5-year period, Inogen's Cost of Revenue averaged around $46.7 million, with its median value being $45.8 million (2019).
  • In the last 5 years, Inogen's Cost of Revenue soared by 5444.76% in 2018 and then plummeted by 2341.49% in 2020.
  • Over the past 5 years, Inogen's Cost of Revenue (Quarter) stood at $43.0 million in 2018, then grew by 4.73% to $45.0 million in 2019, then dropped by 11.28% to $39.9 million in 2020, then decreased by 5.27% to $37.8 million in 2021, then skyrocketed by 65.52% to $62.6 million in 2022.
  • Its last three reported values are $62.6 million in Q3 2022, $57.1 million for Q2 2022, and $37.8 million during Q4 2021.